PHAXIAM Therapeutics S.A. Lease Liabilities
PHAXIAM Therapeutics S.A. had Lease Liabilities of EUR 3.39 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes › Leases
ifrs-full:LeaseLiabilities · last filed 2023-09-26
- 2023-06-30: Lease Liabilities 3.39M EUR.
- 2022-12-31: Lease Liabilities 3.46M EUR.
- 2022-06-30: Lease Liabilities 4.01M EUR.
- 2021-12-31: Lease Liabilities 9.98M EUR.
| Period end | Lease Liabilities | Lease Liabilities as first filed |
|---|---|---|
| 2023-06-30 | 3.39M EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 3.46M EUR 6-K · filed 2023-09-26 | |
| 2022-06-30 | 4.01M EUR 6-K · filed 2022-09-12 | |
| 2021-12-31 | 9.98M EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 10.55M EUR 6-K · filed 2021-09-20 | |
| 2020-12-31 | 10.80M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 12.12M EUR 6-K · filed 2020-09-21 | |
| 2019-12-31 | 12.70M EUR 20-F · filed 2023-03-28 | |
| 2019-06-30 | 8.87M EUR 6-K · filed 2019-09-26 | |
| 2019-01-01 | 7.73M EUR 20-F · filed 2020-03-18 | |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-08 | 8.27M EUR 20-F · filed 2019-03-29 |